Literature DB >> 1316274

Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo.

M E Cardenas1, Q Dang, C V Glover, S M Gasser.   

Abstract

The decatenation activity of DNA topoisomerase II is essential for viability as eukaryotic cells traverse mitosis. Phosphorylation has been shown to stimulate topoisomerase II activity in vitro. Here we show that topoisomerase II is a phosphoprotein in yeast and that the level of incorporated phosphate is significantly higher at mitosis than in G1. Comparison of tryptic phosphopeptide maps reveals that the major phosphorylation sites in vivo are targets for casein kinase II. Incorporation of phosphate into topoisomerase II is nearly undetectable at the non-permissive temperature in a conditional casein kinase II mutant. The sites modified by casein kinase II are located in the extreme C-terminal domain of topoisomerase II. This domain is absent in prokaryotic and highly divergent among eukaryotic type II topoisomerases, and may serve to regulate functions of topoisomerase II that are unique to eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316274      PMCID: PMC556636          DOI: 10.1002/j.1460-2075.1992.tb05230.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Preparation and characterization of yeast nuclear extracts for efficient RNA polymerase B (II)-dependent transcription in vitro.

Authors:  J M Verdier; R Stalder; M Roberge; B Amati; A Sentenac; S M Gasser
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 2.  Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II.

Authors:  H Meisner; M P Czech
Journal:  Curr Opin Cell Biol       Date:  1991-06       Impact factor: 8.382

3.  Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase.

Authors:  M Peter; J Nakagawa; M Dorée; J C Labbé; E A Nigg
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

4.  In vivo phosphorylation of the 170-kDa form of eukaryotic DNA topoisomerase II. Cell cycle analysis.

Authors:  M M Heck; W N Hittelman; W C Earnshaw
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

5.  Purification and characterisation of bovine brain protein kinase C isotypes alpha, beta and gamma.

Authors:  R M Marais; P J Parker
Journal:  Eur J Biochem       Date:  1989-06-01

6.  Casein kinase II enhances the DNA binding activity of serum response factor.

Authors:  J R Manak; N de Bisschop; R M Kris; R Prywes
Journal:  Genes Dev       Date:  1990-06       Impact factor: 11.361

7.  Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae.

Authors:  S T Worland; J C Wang
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

8.  Purification and characterization of type II DNA topoisomerase from mouse FM3A cells: phosphorylation of topoisomerase II and modification of its activity.

Authors:  M Saijo; T Enomoto; F Hanaoka; M Ui
Journal:  Biochemistry       Date:  1990-01-16       Impact factor: 3.162

9.  The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.

Authors:  D W Meek; S Simon; U Kikkawa; W Eckhart
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle. Phosphorylation of site 5 by glycogen synthase kinase-5 (casein kinase-II) is a prerequisite for phosphorylation of sites 3 by glycogen synthase kinase-3.

Authors:  C Picton; J Woodgett; B Hemmings; P Cohen
Journal:  FEBS Lett       Date:  1982-12-13       Impact factor: 4.124

View more
  53 in total

1.  Mutations in the C-terminal domain of topoisomerase II affect meiotic function and interaction with the casein kinase 2 beta subunit.

Authors:  D Leroy; G C Alghisi; E Roberts; O Filhol-Cochet; S M Gasser
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Expression and regulation of protein kinase CK2 during the cell cycle.

Authors:  D G Bosc; B Lüscher; D W Litchfield
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 3.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

Review 4.  Topoisomerase II: its functions and phosphorylation.

Authors:  S M Gasser; R Walter; Q Dang; M E Cardenas
Journal:  Antonie Van Leeuwenhoek       Date:  1992-08       Impact factor: 2.271

5.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

6.  A global view of CK2 function and regulation.

Authors:  Allison Poole; Tim Poore; Sricharan Bandhakavi; Richard O McCann; David E Hanna; Claiborne V C Glover
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

7.  Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2A.

Authors:  Alexandre E Escargueil; Annette K Larsen
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

Review 8.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

9.  Casein kinase II mediates multiple phosphorylation of Saccharomyces cerevisiae eIF-2 alpha (encoded by SUI2), which is required for optimal eIF-2 function in S. cerevisiae.

Authors:  L Feng; H Yoon; T F Donahue
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  A multicopy suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 encodes a protein kinase and is identified as CDC5.

Authors:  K Kitada; A L Johnson; L H Johnston; A Sugino
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.